233 related articles for article (PubMed ID: 9669410)
1. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.
Bergström M; Lu L; Fasth KJ; Wu F; Bergström-Pettermann E; Tolmachev V; Hedberg E; Cheng A; Långström B
J Nucl Med; 1998 Jul; 39(7):1273-9. PubMed ID: 9669410
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of [76Br]bromofluorodeoxyuridine and its validation with regard to uptake, DNA incorporation, and excretion modulation in rats.
Lu L; Bergström M; Fasth KJ; Langström B
J Nucl Med; 2000 Oct; 41(10):1746-52. PubMed ID: 11038007
[TBL] [Abstract][Full Text] [Related]
3. Elimination of nonspecific radioactivity from [76Br]bromide in PET study with [76Br]bromodeoxyuridine.
Lu L; Bergström M; Fasth KJ; Wu F; Eriksson B; Långström B
Nucl Med Biol; 1999 Oct; 26(7):795-802. PubMed ID: 10628559
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker.
Gudjonssona O; Bergström M; Kristjansson S; Wu F; Nyberg G; Fasth KJ; Långström B
Nucl Med Biol; 2001 Jan; 28(1):59-65. PubMed ID: 11182565
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging.
Toyohara J; Kumata K; Fukushi K; Irie T; Suzuki K
J Nucl Med; 2006 Oct; 47(10):1717-22. PubMed ID: 17015909
[TBL] [Abstract][Full Text] [Related]
6. In vitro PET evaluations in lung cancer cell lines.
Xing T; Wu F; Brodin O; Fasth KJ; Långström B; Bergström M
Anticancer Res; 2000; 20(3A):1375-80. PubMed ID: 10928046
[TBL] [Abstract][Full Text] [Related]
7. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers.
Lu L; Samuelsson L; Bergström M; Sato K; Fasth KJ; Långström B
J Nucl Med; 2002 Dec; 43(12):1688-98. PubMed ID: 12468521
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell spheroids as a model for evaluation of metabolic changes after irradiation.
Senekowitsch-Schmidtke R; Matzen K; Truckenbrodt R; Mattes J; Heiss P; Schwaiger M
J Nucl Med; 1998 Oct; 39(10):1762-8. PubMed ID: 9776284
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine.
Böni R; Bläuenstein P; Dummer R; von Schulthess GK; Schubiger PA; Steinert HC
Melanoma Res; 1999 Dec; 9(6):569-73. PubMed ID: 10661767
[TBL] [Abstract][Full Text] [Related]
12. Divalent cobalt as a label to study lymphocyte distribution using PET and SPECT.
Korf J; Veenma-van der Duin L; Brinkman-Medema R; Niemarkt A; de Leij LF
J Nucl Med; 1998 May; 39(5):836-41. PubMed ID: 9591586
[TBL] [Abstract][Full Text] [Related]
13. An ELISA-based method for the quantification of incorporated BrdU as a measure of cell proliferation in vivo.
Behl B; Klos M; Serr M; Ebert U; Janson B; Drescher K; Gross G; Schoemaker H
J Neurosci Methods; 2006 Nov; 158(1):37-49. PubMed ID: 16780957
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
15. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
16. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
[TBL] [Abstract][Full Text] [Related]
17. In vivo distribution and identification of 11C-activity after injection of [methyl-11C]thymidine in Wistar rats.
Goethals P; van Eijkeren M; Lemahieu I
J Nucl Med; 1999 Mar; 40(3):491-6. PubMed ID: 10086716
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of 76Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties.
Lövqvist A; Lundqvist H; Lubberink M; Tolmachev V; Carlsson J; Sundin A
Med Phys; 1999 Feb; 26(2):249-58. PubMed ID: 10076983
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent segmentation of BrdU-signal leads to late detection problems in studies using BrdU as cell label or proliferation marker.
Sauerzweig S; Baldauf K; Braun H; Reymann KG
J Neurosci Methods; 2009 Feb; 177(1):149-59. PubMed ID: 19007815
[TBL] [Abstract][Full Text] [Related]
20. The possible use for immunohistochemical detection of cells in S-phase labeled by bromodeoxyuridine.
Mokrý J; Nĕmecek S; Adler J; Pokorná P
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(1-2):5-15. PubMed ID: 8165431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
